BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38168113)

  • 1. miR-199a/b-3p inhibits HCC cell proliferation and invasion through a novel compensatory signaling pathway DJ-1\Ras\PI3K/AKT.
    Ma LN; Wu LN; Liu SW; Zhang X; Luo X; Nawaz S; Ma ZM; Ding XC
    Sci Rep; 2024 Jan; 14(1):224. PubMed ID: 38168113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-199a-3p suppresses the invasion and metastasis of nasopharyngeal carcinoma through SCD1/PTEN/AKT signaling pathway.
    Hu W; Wang Y; Zhang Q; Luo Q; Huang N; Chen R; Tang X; Li X; Luo H
    Cell Signal; 2023 Oct; 110():110833. PubMed ID: 37543098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of AURKA/miR-199b-3p in hepatocellular carcinoma cells.
    Li G; Tian Y; Gao Z
    J Clin Lab Anal; 2022 Dec; 36(12):e24758. PubMed ID: 36377304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ-ZEB1 promotes PIK3CA expression by silencing miR-199a-3p and affects the proliferation and apoptosis of hepatocellular carcinoma.
    Liu W; Zheng L; Zhang R; Hou P; Wang J; Wu L; Li J
    Mol Cancer; 2022 Mar; 21(1):72. PubMed ID: 35277182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.
    Guo XL; Wang HB; Yong JK; Zhong J; Li QH
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6667-6677. PubMed ID: 30402839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma.
    Ren K; Li T; Zhang W; Ren J; Li Z; Wu G
    J Biomed Sci; 2016 Nov; 23(1):79. PubMed ID: 27832779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-199a-3p inhibits the proliferation, migration, and invasion of endothelial cells and retinal pericytes of diabetic retinopathy rats through regulating FGF7 via EGFR/PI3K/AKT pathway.
    Zhou L; Zhang S; Zhang L; Li F; Sun H; Feng J
    J Recept Signal Transduct Res; 2021 Feb; 41(1):19-31. PubMed ID: 32586178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
    Wang L; Liu WX; Huang XG
    Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-92a-3p Promotes the Malignant Progression of Hepatocellular Carcinoma by Mediating the PI3K/AKT/mTOR Signaling Pathway.
    Wang L; Cui M; Qu F; Cheng D; Yu J; Tang Z; Cheng L; Wei Y; Wu X; Liu X
    Curr Pharm Des; 2021; 27(29):3244-3250. PubMed ID: 34126886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-382-5p promotes cell invasion in hepatocellular carcinoma by targeting PTEN to activate PI3K/Akt signaling pathway.
    Lv B; Liu X; Zhu X; Huang M
    World J Surg Oncol; 2022 Jun; 20(1):175. PubMed ID: 35655254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151.
    Kim JH; Badawi M; Park JK; Jiang J; Mo X; Roberts LR; Schmittgen TD
    Int J Oncol; 2016 Nov; 49(5):2037-2045. PubMed ID: 27599545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
    Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT
    Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-3682-3p Activated by c-Myc Aggravates the Migration and Stemness in Hepatocellular Carcinoma Cells by Regulating PTEN/PI3K/AKT/β-Catenin Signaling.
    Zhang Y; Cai H; Wu MH; Zhu DH; Wang XY; Chen ZY; Yang L; Liu P; Liu Z
    Dig Dis; 2023; 41(3):447-457. PubMed ID: 36366818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-1178-3p suppresses the growth of hepatocellular carcinoma by regulating transducin (beta)-like 1 X-linked receptor 1.
    Pan Q; Shao Z; Zhang Y; Liu H
    Hum Cell; 2021 Sep; 34(5):1466-1477. PubMed ID: 34125401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-206 prevents hepatocellular carcinoma growth and metastasis via down-regulating CREB5 and inhibiting the PI3K/AKT signaling pathway.
    Chi Y; Gong Z; Xin H; Wang Z; Liu Z
    Cell Cycle; 2022 Dec; 21(24):2651-2663. PubMed ID: 36003063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-148a Inhibits Hepatocellular Carcinoma Cell Growth via Epithelial-to-Mesenchymal Transition and PI3K/AKT Signaling Pathways by Targeting Death Receptor-5.
    Zhang N; Zhou J; Zhou Y; Guan F
    Appl Biochem Biotechnol; 2022 Jun; 194(6):2731-2746. PubMed ID: 35267120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
    Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N
    Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.